logo
feed-bg-blur
feed-bg

NeoChem Bio Solutions Ltd. IPO — Is This Speciality Chem Challenger Ready to Scale?

As India’s speciality chemicals wave gets louder, Neochem enters the arena looking to prove it can be more than just another mid-cap manufacturer.


Let's explore this Upcoming IPO further:


Parameter

Details

Issue Type

100% Fresh Issue 

Issue Size

INR 44.97 Crores

Price Band

INR 93-98 per share

Lot Size

1200 shares

Net Issue

43,56,000 Shares

Listing Platform

NSE SME

Issue Opens

December 2, 2025

Issue Closes

December 4, 2025

Listing Date

December 9, 2025


Before the Deep Dive: What’s Working — and What Isn’t


Strengths

Risks

Diverse portfolio of 350+ formulations across polymers, surfactants, silicones, esters

High working capital needs due to credit cycles, inventory holding, and raw material volatility

Strong presence across textiles, HPC, cleaning, water treatment, paints & coatings

Raw material price swings can hit margins

R&D-backed customisation capability and sustainable/bio-based product focus

Customer concentration risk in certain segments

Pan-India network of 50+ distributors + direct exports

Exposure to global economic slowdowns in export-linked sectors

Low capex needs near term due to existing capacity headroom

Debt levels are still elevated, though improving


Now that you’ve seen the snapshot, let’s unpack the full story behind these numbers and understand the business in context.


The Industry Backdrop: India’s Speciality Chem Moment

India’s speciality chemicals industry is in the middle of a real momentum cycle right now. What this really means is the country has quietly become the world’s “replacement factory” for customised, high-value chemistries as global players diversify away from China. 

The Indian market has demonstrated robust growth, expanding from Rs 2.2 lakh crore in FY19 to an estimated Rs 5 lakh crore in FY25, and is projected to reach Rs 7.5 lakh crore by FY29, registering a CAGR of 10-12% over the next four years. 

Here’s the thing: this isn’t a volume game anymore. Customers want specialised intermediates, long-term development partnerships, and reliable supply, which gives Indian players better pricing discipline and stickier relationships. 


Company Origin Story

Neochem is a four-decade-old speciality performance chemicals maker with a portfolio of 350+ customised formulations spanning polymers, surfactants, silicones and bio-based esters. Its products sit deep inside everyday and industrial ecosystems, all from textile and garment processing to home & personal care, institutional cleaning, water treatment, paints and coatings, construction, paper, rubber, dyes and pigments. 

Its operations run out of a 22,000 MTPA partially automated plant in Moraiya, Ahmedabad, designed for liquid and powder chemistries and supported by 1,350 MT of warehousing. R&D is a core driver, backed by an in-house lab and application centre focused on sustainable, bio-based product development. On the market side, Neochem sells directly to customers and through 50+ authorised distributors across India, along with a growing international footprint, giving it a broad, multi-industry demand base and a steady pipeline for customised solutions.

What NeoChem Actually Sells

Neochem basically makes “helper chemicals” that improve how things are cleaned, dyed, processed, coated, or treated across different industries. Think of them as behind-the-scenes ingredients that make other products work better.

Here’s what they actually make:

1. Textile & Garment Chemicals
 These are chemicals used before, during, and after dyeing or printing fabric.

  • What they do: clean the fabric, help colours stick evenly, make prints sharper, improve softness, and give special finishes.

  • Where they’re used: textile mills, garment washing units, denim laundries, printing units.

2. Home & Personal Care (HPC) Ingredients
 These are ingredients that go into soaps, detergents, shampoos, cleaners, and hygiene products.

  • What they do: create foam, improve cleaning power, make liquids mix better, add shine, and control thickness.

  • Where they’re used: FMCG products, institutional cleaners, home-cleaning brands.

3. Institutional & Industrial Cleaning Chemicals
 These are heavy-duty cleaners for hotels, hospitals, restaurants, factories, and laundries.

  • What they do: clean rooms, kitchens, equipment, floors, fabrics, and maintain hygiene at scale.

  • Where they’re used: commercial laundries, hotels, restaurants, industrial kitchens, and offices.

4. Water Treatment Chemicals
 These are chemicals that keep industrial water systems clean and running smoothly.

  • What they do: prevent scaling, remove colour, control foam, help impurities settle so water becomes reusable.

  • Where they’re used: manufacturing plants, treatment facilities, cooling towers, textile dye houses.

5. Paints & Coatings Additives
 These are additives that make paints smooth, durable, and easy to apply.

  • What they do: stop paint from clumping, improve flow, add shine or matte finish, control foam.

  • Where they’re used: paint companies, construction chemicals, coating manufacturers.

6. Polymers, Surfactants, Silicones & Bio-based Esters
 These are their core chemical building blocks.

  • What they do: act as dispersants (keep ingredients evenly mixed), create foam, reduce friction, add softness or slip, or make products more eco-friendly.

  • Where they’re used: textiles, detergents, cosmetics, lubricants, coatings, agriculture, rubber products, and more.

Capacity: How Much Can NeoChem Really Make?

Fiscal Year 

Installed Capacity (MT)

Actual Production (MT)

Capacity Utilisation (%)

Six months ended Sept 30, 2025

22,000

5,002.12

22.74%*

Fiscal 2025

22,000

9,200.00

41.82%

Fiscal 2024

22,000

7,694.00

34.97%

Fiscal 2023

22,000

5,414.00

24.61%


Neochem’s capacity use has climbed steadily from 24.6% in FY23 to 41.8% in FY25, and there’s still plenty of headroom before any major capex is needed. The FY25 jump basically reflects stronger traction in textiles, cleaning chemicals and HPC — meaning the plant is finally working efficiently.

The heavy lifting is backed by a strong in-house R&D setup that enables over 350 customised formulations, plus 1,350 MT of warehousing, which keeps inventory tight and turnaround quick. Put simply, the infrastructure is built for scale, and now the utilisation is starting to catch up.


Where Does the Money Come From?


Revenue Segmentation by Sector

Textiles still dominate Neochem’s revenue stack, because that’s where most of its legacy product lines sit. But here’s where things get interesting: HPC (home & personal care) and paints & coatings are steadily scaling, showing the company’s shift toward higher-value, more diversified end-use markets.

Revenue Mix (₹ in lakhs)

Industry

6M FY26

%

FY25

%

FY24

%

FY23

%

Textile

3,530

77.03%

7,175

85.24%

5,457

90.75%

4,384

95.92%

HPCI

651

14.21%

867

10.30%

310

5.16%

99

2.18%

Paint & Coatings

362

7.90%

310

3.69%

231

3.85%

68

1.50%

Dyes

39

0.86%

64

0.76%

14

0.25%

18

0.40%

Total

4,583

100%

8,417

100%

6,014

100%

4,570

100%



Revenue Segmentation by Product Segment

This breakdown shows what’s really driving the business: polymers and surfactants. These two categories alone make up ~70%+ of revenue, reflecting Neochem’s strength in formulations that enable mixing, coating, dyeing, washing, and stabilising across industries.

(₹ in lakhs)

Segment

6M FY26

%

FY25

%

FY24

%

FY23

%

Esters

841

18.35%

1,148

13.65%

784

13.04%

383

8.38%

Polymers

1,628

35.54%

3,644

43.30%

3,096

51.49%

2,569

56.21%

Silicones

400

8.73%

1,019

12.12%

582

9.69%

369

8.07%

Surfactants

1,712

37.37%

2,603

30.93%

1,550

25.78%

1,249

27.34%

Total

4,583

100%

8,417

100%

6,014

100%

4,570

100%



Geographical Revenue Segmentation

Neochem’s revenue stack is still overwhelmingly domestic, but the mix is slowly widening. India contributed 94.3% of revenue in the first half of FY26 and 91.4% in FY25, with exports inching up from 8–10% over the last three years.

The early signs are clear: smaller but fast-growing markets like Bangladesh, Australia, Vietnam, Egypt, and Singapore are becoming steady contributors, showing that Neochem’s formulations travel well beyond India’s textile and HPC hubs. The company’s push into Oceania, Southeast Asia, Central Asia, and select African/Middle Eastern pockets hints at a deliberate shift — moving from a domestic-heavy business to a broader regional supplier where margins and demand consistency can be stronger.

Management + Promoter Holding

Neochem is led by Swapnil Rameshbhai Makati, a chemical engineer with over 20 years of industry experience, backed by a senior team that covers manufacturing, technical development, finance, and market expansion. The leadership has grown the company through multiple transitions — from a partnership firm to a specialised performance chemicals manufacturer with advanced R&D, zero-liquid-discharge operations, and a global customer base. 

From a control standpoint, the promoters hold a dominant 83.16% stake pre-issue (Swapnil Makati at 74.54% and Hemangini Dathia at 8.62%). Post-IPO, this stake will dilute to 66.7% but promoter influence will remain firmly intact, given their high base ownership and board control. 


Financial Performance 


Particulars

6M FY26 

FY25

FY24

FY23

Revenue from Operations (₹ lakh)

4,583

8,417

6,114

4,818

Total Income (₹ lakh)

4,718

8,615

6,200

4,879

EBITDA (₹ lakh)

859

1,311

599

422

EBITDA Margin (%)

18.75%

15.58%

9.80%

8.77%

PAT (₹ lakh)

548

775

180

107

PAT Margin (%)

11.62%

9.00%

2.91%

2.20%

Cash Profit After Tax (₹ lakh)

611

907

302

228

Net Worth (₹ lakh)

3,223

1,975

1,200

805

Current Ratio (x)

1.45

1.21

1.17

1.09

Debt–Equity (x)

1.20

1.80

2.78

3.26

Return on Equity (%)

21.10%*

48.82%

17.97%

18.07%

Return on Capital Employed (%)

22.84%*

41.67%

21.46%

17.46%


Margins jumped sharply, with EBITDA margin climbing from ~9% in FY24 to 15.6% in FY25, and hitting 18.75% in the first half of FY26. That’s a big shift toward higher-value formulations and better cost control.

PAT margin has 4x’d in three years — from 2.2% (FY23) to 9% (FY25) — showing the operating leverage finally kicking in as capacity utilisation rises.

Debt-equity falling from 3.26x → 1.20x signals real balance-sheet repair and improved cash generation.

ROE and ROCE surged in FY25, with ROE at 48.8% and ROCE at 41.7%, placing Neochem well above many listed peers.

Topline has grown steadily, but the real unlock is the margin expansion, not just the revenue climb.


Peer Analysis

 (in Crs.)

Name of the company

Revenue FY25

EBITDA Margin 

PAT Margin

P/E Ratio 

ROE (%)

Neochem Bio Solutions

84

15.6%

9%

15.3

48.8

Rossari Biotech

2080

12.8%

6.6%

24.7

12.21

Indian Emulsifiers

101

19.4%

13.1%

10.9

24.08


Neochem sits in a sweet spot as its EBITDA (15.6%) and PAT margins (9%) are stronger than Rossari’s and competitive with Indian Emulsifiers, despite being a much smaller company. Its ROE of 48.8% is the standout metric in the entire peer set, signalling sharp capital efficiency. And with a P/E of ~15.3x, it’s priced more reasonably than Rossari while still commanding stronger profitability momentum than most listed peers.

IPO Objectives

The company will be using the proceeds for:

  • Funding the long-term working capital requirements of the Company 

  • Repayment/prepayment, in full or part, of all or certain outstanding borrowings 

  • General Corporate Purposes* 


Final words


Looking through LMVT:

Leadership: Promoters know the chemistry game well, but the bench is still thin, and execution rests heavily on them.
Moat: Custom formulations and sticky B2B relationships help, but nothing here is uncopyable — competitors can catch up with capex and R&D.
Valuation: The ask isn’t bargain territory; margins have improved sharply, but the pricing already bakes in that momentum.
Tailwinds: Speciality chemicals in India are riding strong export demand and China+1 traction, giving solid sector-level support.

Bottom line: Neochem is growing fast with improving fundamentals, but the moat isn’t deep, and valuation demands faith in continued execution. This is a selective, not automatic, buy.

0

eye

9

share

0

Publish Date

04 Dec 2025

Category

SME IPO

Reading Time

10 mins

Social Presence

icons
icons
icons
icons
icons

Tags

SME IPO

SME IPO review

NeoChem Bio Solutions IPO

logo

Office Address: MiQB, Plot 23, Sector 18, Maruti Industrial Development Area, Gurugram, Haryana 122015

Registered Office Address: 1001, Block G1B, Pocket-1, Phase-2, Samriddhi Apartments, Dwarka Sector-18B, New Delhi-110078

Email: help@alphaamc.com Phone: +91-93-1137-8001

Alpha Ventures Private Limited

(Formerly known as Planify WealthX Pvt Ltd)

Sponsor Name

CIN:U70200DL2023PTC419808
PAN:AAOCP0750H

VentureX Fund I

Fund Name

PAN:AAETV3779K
SEBI Regn No:IN/AIF1/24-25/1565

Planify Venture LLP

Investment Manager

PAN:ABEPF1917C
LLP Identification Number:ACC-6910
GSTIN:07ABEPF1917C1ZL

Disclaimer

You acknowledge and confirm that by accessing the website, you are seeking information relating to the organisation of your own accord and that there has been no form of solicitation, advertisement or inducement by the organisation. Any part of the content is not, and should not be construed as, an offer or solicitation to buy or sell any securities or make any investments or any products. No material/information provided on this website should be construed as investment advice. Any action on your part on the basis of the said content is at your own risk and responsibility.

© 2024–2026 Alpha. All rights reserved, Built with ❤️ in India

Home

Invest

AIF

Shorts

More